An Evaluation of Some Dihydrogenated Alkaloids of Ergot in the Management of Chronic Peripheral Vascular Diseases

Popkin, R.J. : Dihydrogenated alkaloids of ergot in treatment of peripheral vascular diseases . California Med., 72: 108, 1950.

Dale, H.H. : On some physiological actions of ergot. J. Physiol. , 34: 163, 1906.

Stoll, A. AND Hoffman, A. : Die Dihydroderivate der naturlichen linksdrehenden Mutterkornalkaloide . Helvet. chim. Acta. 26: 2070, 1943.

Rothlin, E. : The pharmacology of the natural and dihyrogenated alkaloids of ergot . Bull. schweiz. Akad. d. med. Wissench., 2: 249, 1947.

Bluntschli, H.J. : Clinical observations on the sympathetic inhibitory effects of a new ergot alkaloid. South African M. J., 21: 21-23, 1947.

Bluntschli, H.J. AND Goetz, R.H. : The effect of a new sympathicolytic drug (dihydroergocornine) on the blood pressure with special reference to hypertension . South African M. J., 21: 382, 1947.

Bluntschli, H.J. AND Goetz, R.H. : The effect of ergot derivatives on the circulation in man with special reference to two new hydrogenated compounds (dihydroergotamine and dihydroergocornine). Am. Heart J., 35: 873, 1948.

Avera, J.W. , Hoobler, S.W. , McClellan, S.G. AND Little, W.J. : Quantitative estimates of vasomotor tone in the human extremity with comparative studies of the sympathetic blocking and adrenolytic properties of Tetraethylammonium, Priscol and Dihydroergocornine. Am. J. Med., 7: 423, 1949.

Bennett, W.D. , Dhuner, K.G. AND Orth, O.S. : A comparison of the effectiveness of dihydroergotamine (DHE 45) and dihydroergocornine (DHO 180) in the prevention of cardiac irregularities during cycloprane anaesthesia . J. Pharmacol. and Exper. Therap. , 95: 287, 1949 .

Bircher,R. AND Cerletti, A. : Unterrsuchungen uber die Wirkung neuer dihydrieter Mutterkornalkaloide bei peripheren Durchblutungsstorungen und Hypertonie. Helv. med. Acta, 16: 13 (1949) (Suppl. 22).

Cerletti, A. , Bircher, R. AND Rothlin, E. : Protective Wirkung von CCK 179 (Hydergin) auf die Entstehung der corticalen Nierenischamie (sog. Oxfordshunt). Helv. Physiol. Acta, 7: 107, 1949.

Freudiger, A. AND Rothlin, E. : Ueber die Wirkung der naturlichen und dihydrierten Mutterkornalkaloide auf das isolierte Froschherz. Arch. internat. de pharmacodyn et de therap. 78: 445, 1949.

Freis, E.D. , Stanton, J.R. , Litter , J. , Culbertson, J.W. , Halperin, M.H. , Moister, F.C. AND Wilkins, R.W. : Hemodynamic effects of hypotensive drugs in man. II. Dihydroergocornine. J. Clin. Investigation, 28: 1387, 1949.

Goetz, R.H. AND Katz, A. : The adrenolytic action of dihydroergocornine in man. Lancet, 1: 560, 1949.

Hayes, D.W. , Wakim, K.G. , Horton , B.T. AND Peters, G.A. : The effects of dihydroergocornine on the circulation in the extremities of man. J. Clin. Investigation, 28: 615, 1949.

Josephs, I.L. : Clinical observations on the hypertensive effect of certain dihydrogenated alkaloids of ergot in human beings. Am. Pract. 4: 71, 1949.

Kappert, A. , Baumgartner, P. , Daguet , A. , Erard, H. , Rupp, F. , Schorer, D. AND Zurcher, H.P. : Untersuchungen uber die Wirkungen neuer dihydrierter Mutterkornalkaloide bei peripheren Durchblutungsstorungen und Hypertonie. Helv. Med Acta, 16: 1, 1949 (Suppl. 22).

Nickerson, M. : The pharmacology of adrenergic blockade. J. Pharmacol. and Exper. Therap., 95: 27, 1949 (Part II).

Scherf, D. , Perlman, A. , AND Schlachman, M. : Effect of dihydroergocornine on the heart. Proc. Soc. Exper. Biol. and Med., 71: 420, 1949.

Smith, J.A. AND Zalman, S. : Some effects of large doses of ergot products on rats. Proc. Soc. Exper. Biol. and Med., 72: 13, 1949.

Stanley, A. AND Gubner, H. : Effect of adrenolytic compound, dihydroergocornine on epinephrine-induced stimulation of the adrenal cortex. Bull. New York Acad. Med. , 25: 446, 1949.

Stanton, J.R. , Ware, P.F. AND Statzman, J.W. : CCK-179 in the prophylaxis of cardiac arrhythmias in the dog. Presented at the Eastern Section Meeting of the Am. Fed. for Clinical Research. Boston, Dec. 3, 1949.

Crosley, JR. A.P. , Cummins, A.J. , Barker , H.G. AND Clark, J.K. : The renal hemodynamic effects of dihydroergocornine (DHO 180) in man. J. Pharmacol. and Exper. Therap., 98: 138, 1950.

Curry, J.J. , Fuchs, J.E. AND Leard, S.E. : The effect of dihydroergocornine on the pulmonary response to methacholine and histamine in subjects with bronchial asthma. J. Clin. Investigation, 29: 439, 1950.

Eichler, O. , Heinzel, J. AND Linder, F. : Anwendung Dihydrieter Mutterkornalkaloide (CCK 179=Hydergin) bei Peripheren Durchblutungsstorungen und Anderen Sympathicotonen . Klin. Wchnschr., 28: 298, 1950.

Hafkenschiel, J.H. , Crumpton, C.W. AND Moyer, J.H. : The effect of dihydroergocornine on the cerebral circulation in normotensive patients . J. Pharmacol. and Exper. Therap., 98: 144, 1950.

Hafkenschiel, J.H. , Crumpton, C.W. , Moyer , J.H. AND Jeffers, W.A. : The effect of dihydroergocornine on the cerebral circulation of patients with essential hypertension. J. Clin. Investigation, 29: 408, 1950.

Hauss, W.H. , Kreuziger, H. AND Asteroth, H. : Ueber die Wirkung neuerer sympathikolytischer Substanzen. Klin. Wchnschr. , 27: 690, 1950.

Konzelt, H. AND Rothlin, E. : Erregende und hemmende Wirkungen der adrenerigischen Reizubertrager-stoffe. Wien. med. Wchnschr., 100: 57, 1950.

Meier, M. : Zur Therapie peripher Durchblutungsstorungen durch med: kamentose Beeinflussung des vegetativen Nervensystems. (Erfahrungen mit Hydergin und Dilvasene). Praxis, 57: 569, 1950.

Prochnik, G. , Maison, G.L. AND Stutzman, J.W. : Carotid-occlusion-pressor reflex: influence of existing mean arterial pressure, of anaesthetics and ganglionic-and adrenergic-blocking drugs. Am. J. Physiol. ,162: 553, 1950.

Roberts, J.E. , Massopust, L.C. AND Buchanan, A.R. : Effects in albino rats of dihydrogenated derivatives of the dimethylpyruvic acid group of ergot alkaloids as manifested by thermal reactions and oxygen utilization . J. Pharmacol. and Exper. Therap., 100: 51, 1950.

Rothlin, E. AND Cerletti, A. : Beitrag zum Problem sog. Kompetitiver Pharmakodynamischer Effekte. Arch. internat. de pharmacodyn. et de therap., 82: 118, 1950.

Schneider, P.B. : Recherches experimentales et cliniques avec les alcaloides dihydrogenes de l'ergot de seigle (DHE 45, DHO 180, DHK135, DCS 90). Schweiz arch. f. Neurol. u. Psychiat. 65: 283, 1950.

Pordy, L. , Harold, S.A. AND Master, A.M. : Dihydroergocornine in the differential diagnosis of functional heart disturbances and organic heart disease. J. Mt. Sinai Hosp., 17: 26, 1950.

Posner, A. : The effect of certain hydrogenated alkaloids of ergot on glaucoma . Am. J. Ophth., 33: 1551, 1950.

Vodopivec, M. AND Jelavic, N. : Wirkung von Hydergin auf die Gerinnungszeit bei haemophilie. Acta Haemat., 3: 247, 1950.

Winston, B.J. : The use of tetraethylammonium chloride in treatment of phantom limb pain. Circulation, 1: 299, 1950.

Lennox, W.G. , Gibbs, E.L. AND Gibbs, F.A. : Effect of ergotamine tartrate on the cerebral circulation of man. J. Pharmacol. and Exper. Therap., 53: 113, 1935.